For: | Scoville SD, Xourafas D, Ejaz AM, Tsung A, Pawlik T, Cloyd JM. Contemporary indications for and outcomes of hepatic resection for neuroendocrine liver metastases. World J Gastrointest Surg 2020; 12(4): 159-170 [PMID: 32426095 DOI: 10.4240/wjgs.v12.i4.159] |
---|---|
URL: | https://www.wjgnet.com/1948-9366/full/v12/i4/159.htm |
Number | Citing Articles |
1 |
S. Nadalin, M. Peters, A. Königsrainer. Lebermetastasen neuroendokriner Tumoren. Die Chirurgie 2022; 93(7): 659 doi: 10.1007/s00104-022-01656-1
|
2 |
Kylie E Zane, Jordan M Cloyd, Khalid S Mumtaz, Vibhor Wadhwa, Mina S Makary. Metastatic disease to the liver: Locoregional therapy strategies and outcomes. World Journal of Clinical Oncology 2021; 12(9): 725-745 doi: 10.5306/wjco.v12.i9.725
|
3 |
Steven D Scoville, Jordan M Cloyd, Timothy M Pawlik. Treatment of neuroendocrine liver metastases: a patent landscape review. Pharmaceutical Patent Analyst 2020; 9(2): 29 doi: 10.4155/ppa-2020-0009
|
4 |
Francesca Muffatti, Valentina Andreasi, Stefano Partelli, Massimo Falconi. Neuroendocrine Tumors. 2021; : 125 doi: 10.1007/978-3-030-62241-1_8
|